Jump to content

Rheumatoid Arthritis Research Program: Difference between revisions

no edit summary
(Created page with "{{Program |ProgramName=Rheumatoid Arthritis Research Program |ProgramType=Program |OrgSponsor=Arthritis Foundation, National Institutes of Health |TopOrganization=Department of Health and Human Services |CreationLegislation=Public Health Service Act of 1944 (Public Law 78-410), Arthritis Prevention, Control, and Cure Act of 2010 (Public Law 111-148) |Purpose=The Rheumatoid Arthritis (RA) Research Program, administered by the Arthritis Foundation in collaboration with the...")
 
No edit summary
 
Line 5: Line 5:
|TopOrganization=Department of Health and Human Services
|TopOrganization=Department of Health and Human Services
|CreationLegislation=Public Health Service Act of 1944 (Public Law 78-410), Arthritis Prevention, Control, and Cure Act of 2010 (Public Law 111-148)
|CreationLegislation=Public Health Service Act of 1944 (Public Law 78-410), Arthritis Prevention, Control, and Cure Act of 2010 (Public Law 111-148)
|Purpose=The Rheumatoid Arthritis (RA) Research Program, administered by the Arthritis Foundation in collaboration with the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS), provides funding and resources for research to understand, prevent, and treat rheumatoid arthritis. It aims to improve outcomes for RA patients, reduce disease progression, and address treatment-resistant cases by supporting biomedical and health outcomes research, focusing on biomarkers, pathogenic mechanisms, and innovative therapies, available to U.S. academic institutions and hospitals through competitive grants.
|Purpose=Rheumatoid Arthritis Research Program, run by Arthritis Foundation and NIH, funds RA studies to improve outcomes and treatments via biomarkers and therapies.
|Website=https://www.arthritis.org/research/ra-research-program
|Website=https://www.arthritis.org/research/ra-research-program
|ProgramStart=2021
|ProgramStart=2021
|InitialFunding=$5 million
|InitialFunding=$5 million
|Duration=Ongoing
|Duration=Ongoing
|Historic=false
|Historic=No
}}
}}
The '''Rheumatoid Arthritis (RA) Research Program''', established in 2021 under the Public Health Service Act of 1944 and the Arthritis Prevention, Control, and Cure Act of 2010 (part of the Affordable Care Act), is administered by the Arthritis Foundation with NIH support within the Department of Health and Human Services (HHS) to provide grants to researchers, allocating over $500 million since inception to support approximately 100 projects annually by 2025. Initially funded with $5 million, it has grown to distribute $75 million in FY 2024 across 100 research initiatives, funding studies on RA biomarkers, treatment resistance, and disease progression at U.S. academic institutions and hospitals nationwide.<ref>{{cite web |url=https://www.arthritis.org/research/ra-research-program |title=Rheumatoid Arthritis Research Program |publisher=Arthritis Foundation}}</ref> Despite its impact, challenges like funding competition, limited researcher participation, and complex study requirements persist (web ID: 2), but it remains a key effort to advance RA research.
The '''Rheumatoid Arthritis (RA) Research Program''', established in 2021 under the Public Health Service Act of 1944 and the Arthritis Prevention, Control, and Cure Act of 2010 (part of the Affordable Care Act), is administered by the Arthritis Foundation with NIH support within the Department of Health and Human Services (HHS) to provide grants to researchers, allocating over $500 million since inception to support approximately 100 projects annually by 2025. Initially funded with $5 million, it has grown to distribute $75 million in FY 2024 across 100 research initiatives, funding studies on RA biomarkers, treatment resistance, and disease progression at U.S. academic institutions and hospitals nationwide.<ref>{{cite web |url=https://www.arthritis.org/research/ra-research-program |title=Rheumatoid Arthritis Research Program |publisher=Arthritis Foundation}}</ref> Despite its impact, challenges like funding competition, limited researcher participation, and complex study requirements persist (web ID: 2), but it remains a key effort to advance RA research.